News

Firsthand Technology Value Fund Shares Q2 2025 Financial Insights

Firsthand Technology Value Fund Shares Q2 2025 Financial Insights

Firsthand Technology Value Fund's Recent Financial Results

Firsthand Technology Value Fund, Inc. (OTCQB: SVVC) has recently revealed its financial performance for the most recent quarter, providing an insightful look at its operations and future direction. This unique venture capital fund focuses on investing in technology and cleantech companies and is committed to capital growth for its investors.

Overview of Financial Performance

As of the latest reporting, the Fund's net assets stood at roughly $0.7 million, translating to an NAV of $0.11 per share. This is a decrease from the previous figure of $0.8 million or $0.12 per share. The portfolio includes a mix of public and private securities valued at about $0.7 million, with cash and equivalents contributing approximately $0.07 per share.

Investment Portfolio Breakdown

The Fund's investment portfolio encompasses several assets categorized as follows:

  • Equity/Debt Investments: $0.22 million
  • Cash/Cash Equivalents: $0.51 million
  • Other Assets: $0.44 million

All assets culminate in total assets amounting to approximately $1.17 million with total liabilities of $0.42 million.

Valuation Adjustments and Strategy

During Q2, the Valuation Committee—composed of two independent directors—conducted adjustments on the fair values of the Fund’s private company holdings. To determine the accurate valuations, the committee embraced comprehensive evaluations from an independent valuation firm, factoring in various aspects such as the performance of the portfolio companies and recent market activity.

Investment Income and Loss Overview

For the quarter, the Fund reported approximately $171 thousand in total investment income. However, after accounting for fees and expenses, the net investment loss totaled around $63 thousand. The Fund experienced net realized and unrealized losses of about $27 thousand, highlighting the challenging market conditions.

Management Approach

Throughout Q2, the Fund demonstrated a proactive stance in managing its portfolio. This included collaborating closely with portfolio companies and their management teams to boost performance and identify exit opportunities that can benefit shareholders.

About the Fund

Firsthand Technology Value Fund, Inc. is a publicly traded venture capital fund with a mission to enhance shareholder value through strategic investments in technology and cleantech sectors. The Fund emphasizes long-term capital growth and typically invests over 80% of its total assets in these sectors.

Contact Information

For additional details or inquiries, feel free to contact:

Phil Mosakowski
Firsthand Capital Management, Inc.
(408) 624-9526
vc@firsthandtvf.com

Frequently Asked Questions

What is the NAV of Firsthand Technology Value Fund?

The NAV is reported at $0.11 per share as of the latest quarter.

What are the primary sectors Firsthand Technology Value Fund invests in?

The Fund primarily focuses on technology and cleantech companies.

How did the Fund's net investment income perform in Q2?

For Q2, the Fund reported an investment income of approximately $171 thousand.

What steps is the Fund taking to enhance its portfolio performance?

The Fund collaborates with portfolio companies to boost performance and identify exit strategies.

Who should investors contact for more information?

Investors can reach out to Phil Mosakowski at Firsthand Capital Management for further inquiries.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Discover Caron Scientific's Innovative 7406 Incubator Shaker

Updated Category News Views 314

Introducing the 7406 Incubator Shaker by Caron Scientific Caron Scientific, Inc. has raised the bar in environmental testing and laboratory equipment with the launch of their newest innovation: the 7406 Incubator Shaker. Known for its dedication to providing state-of-the-art incubation solutions, Caron Scientific presented this remarkable product at a prominent...

Continue Reading
Markets Steady as Analysts Predict Seasonal Trends Amidst Fluctuations

Updated Category News Views 409

US Stocks Look to Rebound Following Recent Sell-Off U.S. stock futures showed an upward trend recently, bouncing back from a notable sell-off. Most benchmark indices are witnessing gains in premarket trading while the small-cap Russell 2000 remains slightly down. Nvidia's Effects on Technology Sector Nvidia Corp. (NASDAQ: NVDA) experienced a significant decline of over 8%...

Continue Reading
Class Action Update for Avantor, Inc. Investors: Key Info Here

Updated Category News Views 159

Understanding the Avantor, Inc. Class Action Lawsuit Avantor, Inc. (NYSE: AVTR) is a prominent provider of scientific products and services designed to cater to various sectors including biotechnology and pharmaceuticals. This article sheds light on the ongoing class action lawsuit initiated on behalf of investors who acquired shares of Avantor during a specified class...

Continue Reading
Hyphens Pharma Partners with Louis Widmer to Launch Cerapro® MED

Updated Category News Views 118

Hyphens Pharma Collaborates with Louis Widmer for Cerapro® MED Hyphens Pharma International Limited is thrilled to announce a significant partnership with Louis Widmer SA for the commercialization of their innovative product, Cerapro® MED Skin Barrier Cream. This agreement enables Louis Widmer to promote and distribute Cerapro® MED in six European countries. About...

Continue Reading
Tarsus Pharmaceuticals Engages Investors at Key Conference

Updated Category News Views 140

Engagement in a Notable Investor Conference Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) has exciting news for its stakeholders! The company recently declared its participation in an essential fireside chat at the Guggenheim 2nd Annual Healthcare Innovation Conference. This event is set to take place in Boston and will commence at 11:30 a.m. PT / 2:30 p.m. ET on a Tuesday...

Continue Reading